Metabolic Disorders Following Kidney Transplantation

Journal of Renal Nutrition

Volumn 22, Issue 5, 2012, Pages 451-460.e1

  Phillips, Stacey ^a   Heuberger, Rochelle ^a  

^a CENTRAL MICHIGAN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84865394625     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2012.01.022     Document Type: Review

References (68)

1. Cochran C., Kent P. Nutritional management of the adult renal transplant patient. A Clinical Guide to Nutrition Care in Kidney Disease 2004, 71-85. American Dietetic Association, Chicago, IL. 1st ed. L. Byham-Gray, K. Wiesen (Eds.).
2. Kasiske B., Zeier M., Chapman J., et al. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int 2010, 77:299-311.
3. Friedman A., Miskulin D., Rosenberg I., Levey A. Demographics and trends in overweight and obesity in patients at time of kidney transplantation. Am J Kidney Dis 2003, 41:480-487.
4. Sancho A., Ávila A., Gavela E., et al. Effect of overweight on kidney transplantation outcome. Transplant Proc 2007, 39:2202-2204.
5. Hricik D. Metabolic syndrome in kidney transplantation: management of risk factors. Clin J Am Soc Nephrol 2011, 6:1781-1785.
6. Hur K., Kim M., Kim Y., et al. Risk factors associated with the onset and progression of post transplantation diabetes in renal allograft recipients. Diabetes Care 2007, 30:609-615.
7. Ozdemir F., Karakan S., Akqul A., Haberal M. Metabolic syndrome is related to long-term graft function in renal transplant recipients. Transplant Proc 2009, 41:2808-2810.
8. International Diabetes Federation. Rationale for new IDF worldwide definition of metabolic syndrome. Available at: Accessed September 2011. http://www.idf.org/webdata/docs/MetS_def_update2006.pdf.
9. Ucar E., Huzmeli C., Guven O., et al. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions. Ren Fail 2009, 31:221-228.
10. Jalalzadeh M., Mohammadi R., Mirzamohammadi F., Ghadiani M. Prevalence of metabolic syndrome in a hemodialysis population. Iran J Kidney Dis 2011, 5:248-254.
11. De Vries A., Bakker S., Van Son W., et al. Metabolic syndrome is associated with impaired long-term renal allograft function: not all component criteria contribute equally. Am J Transplant 2004, 4:1675-1683.
12. Olarte I., Hawasli A. Kidney transplant complications and obesity. Am J Surg 2009, 197:424-426.
13. Coroas A., Oliveira J., Sampaio S., Tavares I., Pestana M., Almeida M. Postrenal transplantation body composition: different evolution depending on gender. J Ren Nutr 2007, 17:151-156.
14. Moreau K., Chauveau P., Martin S., et al. Long-term evolution of body composition after renal transplantation: 5 year survey. J Ren Nutr 2006, 16:291-299.
15. Clunk K., Lin C., Curtis J. Variables affecting weight gain in renal transplant recipients. Am J Kidney Dis 2001, 38:349-353.
16. Bellinghieri G., Bernardi A., Piva M., et al. Metabolic syndrome after kidney transplantation. J Ren Nutr 2009, 19:105-110.
17. Bernardi A., Biasia F., Pati T., et al. Factors affecting nutritional status, response to exercise, and progression of chronic rejection in kidney transplant patients. J Ren Nutr 2005, 15:54-57.
18. Gordon E., Prohaska T., Gallant M., et al. Longitudinal analysis of physical activity, fluid intake, and graft function among kidney transplant recipients. Transplant Int 2009, 22:990-998.
19. Chatzikyrkou C., Menne J., Gwinner W., et al. Pathogenesis and management of hypertension after kidney transplant. J Hypertens 2011, 29:2283-2294.
20. Opelz G., Döhler B. Improved long-term outcomes after renal transplantation associated with blood pressure control. Am J Transplant 2005, 5:2725-2731.
21. Roland M., Gatault P., Al-Najjar A., et al. Early pulse pressure and low-grade proteinuria as independent long-term risk factors for new-onset diabetes mellitus after kidney transplantation. Am J Transplant 2008, 8:1719-1728.
22. Physiology 2004, McGraw-Hill, New York, NY. 8th ed. A. Vander, J. Sherman, D. Luciano (Eds.).
23. Rodrigo E., Santos L., Piñera C., et al. Early prediction of new-onset diabetes mellitus by fifth-day fasting plasma glucose, pulse pressure, and proteinuria. Transplant Proc 2011, 43:2208-2210.
24. Joss N., Staaz C., Thomson A., Jardine A. Predictors of new onset diabetes after renal transplantation. Clin Transplant 2007, 21:136-143.
25. Chakkera H., Hanson R., Raza S., et al. Pilot study: association of traditional and genetic risk factors and new-onset diabetes mellitus following kidney transplantation. Transplant Proc 2009, 41:4172-4177.
26. Hasse J. Nutrition assessment and support of organ transplant recipients. J Parenter Enteral Nutr 2001, 25:120-131.
27. Porrini E., Delgado P., Alvarez A., et al. The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation. Nephrol Dial Transplant 2008, 23:1436-1441.
28. Gnatta D., Keitel E., Heineck I., et al. Use of tacrolimus and the development of posttransplant diabetes mellitus: a Brazilian single-center, observational study. Transplant Proc 2010, 42:475-478.
29. Boots J., Duijnhoven E., Christiaans M., Wolffenbuttel B., Van Hooff J. Glucose metabolism in renal transplant recipients on tacrolimus: the effect of steroid withdrawal and tacrolimus trough level reduction. J Am Soc Nephrol 2002, 13:221-227.
30. Wilkinson A., Davidson J., Dotta F., et al. Guidelines for the treatment and management of new-onset diabetes after transplantation. Clin Transplant 2005, 19:291-298.
31. Orazio L., Hickman I., Armstrong K., Johnson D., Banks M., Isbel N. Higher levels of physical activity are associated with a lower risk of abnormal glucose tolerance in renal transplant recipients. J Ren Nutr 2009, 9:304-313.
32. Armstrong K., Rakhit D., Jeffriess L., et al. Cardiorespiratory fitness is related to physical inactivity, metabolic risk factors, and atherosclerotic burden in glucose-intolerant renal transplant recipients. Clin J Am Soc Nephrol 2006, 1:1275-1283.
33. Salerno M., Piselli P., Rossi E., et al. Metabolic syndrome and cardiovascular disease in kidney transplantation. Transplant Proc 2011, 43:1067-1068.
34. Courivaud C., Kazory A., Simula-Faivre D., Chalopin J., Ducloux D. Metabolic syndrome and atherosclerotic events in renal transplant recipients. Transplantation 2007, 83:1577-1581.
35. Young J., Neumayer H., Gordon R. Pretransplant cardiovascular evaluation and posttransplant cardiovascular risk. Kidney Int 2010, 78(suppl 118):S1-S7.
36. Hines L. Can low-fat/cholesterol nutrition counseling improve food intake habits and hyperlipidemia of renal transplant patients?. J Ren Nutr 2000, 10:30-35.
37. Stachowska E., Wesolowska T., Safranow K., et al. Simple dietary intervention reduce the risk factors of atherosclerosis in renal graft recipients. J Ren Nutr 2005, 15:291-297.
38. Rike A., Mogilishetty G., Alloway R., et al. Cardiovascular risk, cardiovascular events, and metabolic syndrome in renal transplantation: comparison of early steroid withdrawal and chronic steroids. Clin Transplant 2008, 22:229-235.
39. Perrea D., Moulakakis K., Poulakou M., Vlachos I., Nikiteas N., Kostakis A. Correlation between lipid abnormalities and immunosuppressive therapy in renal transplant recipients with stable renal function. Int Urol Nephrol 2008, 40:521-527.
40. Molnar M., Kovesdy C., Bunnapradist S., et al. Associations of pretransplant serum albumin with post-transplant outcomes in kidney transplant recipients. Am J Transplant 2011, 11:1006-1015.
41. Yelken B., Gorgulu N., Caliskan Y., et al. Comparison with nutritional status in hemodialysis patients with and without failed renal allografts. Clin Transplant 2010, 24:418-487.
42. Dahlberg R., Muth B., Samaniego M., Hofmann R., Pirsch J., Djamali A. One year serum albumin is an independent predictor of outcomes in kidney transplant recipients. J Ren Nutr 2010, 20:392-397.
43. Souza G., Costa C., Scalco R., Gonçalves L., Manfro R. Serum leptin, insulin resistance, and body fat after renal transplantation. J Ren Nutr 2008, 18:479-488.
44. Prasad G., Huang M., Bandukwala F., et al. Pre-transplantation glucose testing for predicting new-onset diabetes mellitus after renal transplantation. Clin Nephrol 2009, 71:140-146.
45. Luan F., Stuckey L., Ojo A. Abnormal glucose metabolism and metabolic syndrome in non-diabetic kidney transplant recipients early after transplantation. Transplantation 2010, 89:1034-1039.
46. Alexander M., Patel T., Farag Y., Florez A., Rennke H., Singh A. Kidney pathological changes in metabolic syndrome: a cross-sectional study. Am J Kidney Dis 2009, 53:751-759.
47. Coroas A., Oliveira J., Sampaio S., et al. Bioimpedance analysis highlights changes in body composition at the early stages of impairment of kidney function. J Ren Nutr 2004, 14:157-163.
48. Djamali A., Pietrangeli C., Gordon R., Legendre C. Potential of emerging immunosuppressive strategies to improve the posttransplant cardiovascular risk profile. Kidney Int 2010, 78(suppl 118):S15-S21.
49. Goldsmith D., Pietrangeli C. The metabolic syndrome following kidney transplantation. Kidney Int 2010, 78(suppl 118):S8-S14.
50. Sui W., Zou H., Zou G., et al. Clinical study of the risk factors of insulin resistance and metabolic syndrome after kidney transplantation. Transplant Immunol 2008, 20:95-98.
51. Mazali F., Lalli C., Alves-Filho G., Mazzali M. Posttransplant diabetes mellitus: incidence and risk factors. Transplant Proc 2008, 40:764-766.
52. Ekberg H., Tedesco-Silva H., Demirbas A., et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 2007, 357:2562-2575.
53. Johnston O., Rose C., Webster A., Gill J. Sirolimus is associated with new-onset diabetes mellitus in renal transplant recipients. J Am Soc Nephrol 2008, 19:1411-1418.
54. Araki M., Flechner S., Ismail H., et al. Posttransplant diabetes mellitus in kidney transplant recipients receiving calcineurin or MTOR inhibitor drugs. Transplantation 2006, 81:335-341.
55. Woodle E., First M., Pirsch J., et al. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy. Ann Surg 2008, 248:564-577.
56. Van Dem Ham E., Kooman J., Christiaans M., Nieman F., Van Hooff J. Weight changes after renal transplantation: a comparison between patients on 5 mg maintenance steroid therapy and those on steroid-free immunosuppressive therapy. Transplant Int 2003, 16:300-306.
57. Heaf J., Jakobsen U., Tvedegaard E., Kanstrup I., Fogh-Andersen N. Dietary habits and nutritional status of renal transplant patients. J Ren Nutr 2004, 14:20-25.
58. Cupisti A., D'Alessandro C., Ghiadoni L., Morelli E., Panichi V., Barsotti G. Effect of a soy protein diet on serum lipids of renal transplant patients. J Ren Nutr 2004, 14:31-35.
59. Lynch I., Eustace J., Plant W., et al. Inadequate dietary calcium and vitamin D intakes in renal-transplant recipients in Ireland. J Ren Nutr 2007, 17:408-415.
60. Torres M., Gioseffi C., Montiero S., et al. A pilot study on the relation between dietary calcium and clinical parameters in renal transplant recipients. J Ren Nutr 2011, 21:418-425.
61. Noori N., Nafar M., Poorrezagholi F., et al. Dietary intakes of fiber and magnesium and incidence of metabolic syndrome in first year after renal transplantation. J Ren Nutr 2010, 20:101-111.
62. Orazio L., Isbel N., Armstrong K., et al. Evaluation of dietetic advice for modification of cardiovascular disease risk factors in renal transplant recipients. J Renal Nutr 2011, 21:462-471.
63. Teplan V. Effect of keto acids on asymmetric dimethylarginine, muscle, and fat tissue in chronic kidney disease and after kidney transplantation. J Ren Nutr 2009, 19(suppl):S27-S29.
64. Nafar M., Noori N., Jalali-Farahani S., et al. Mediterranean diets are associated with a lower incidence of metabolic syndrome 1 year following renal transplantation. Kidney Int 2009, 76:1199-1206.
65. Bostom A., Carpenter M., Kusek J., et al. Homecysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients. Circulation 2011, 123:1763-1770.
66. Guida B., Trio R., Laccetti R., et al. Role of dietary intervention on metabolic abnormalities and nutritional status after renal transplantation. Nephrol Dial Transplant 2007, 22:3304-3310.
67. Johnson D., Isbel N., Brown A., et al. The effect of obesity on renal transplant outcomes. Transplantation 2002, 74:675-681.
68. Bostom A., Carpenter M., Hunsicker L., et al. Baseline characteristics of participants in the folic acid for vascular outcome reduction in transplantation (FAVORIT) trial. Am J Kidney Dis 2009, 53:121-128.